New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 2, 2024 - Rovi announced the FDA approval of Risvan (risperidone), for the treatment of schizophrenia in adults.
Download PDF
Return to publications
